Cargando…
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
BACKGROUND: PCDH10, one of the non-clustered protocadherins, is identified as a tumor suppressor gene in many tumors. Recently, promoter methylation of PCDH10 was found in diffuse large B-cell lymphoma (DLBCL) but not in normal lymph nodes, suggesting that its epigenetic aberrance is essential to th...
Autores principales: | Huang, Wenting, Xue, Xuemin, Shan, Ling, Qiu, Tian, Guo, Lei, Ying, Jianming, Lu, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715993/ https://www.ncbi.nlm.nih.gov/pubmed/29202805 http://dx.doi.org/10.1186/s12885-017-3810-7 |
Ejemplares similares
-
Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients
por: Deng, Qiu-Kui, et al.
Publicado: (2016) -
Promoter methylation of PCDH10 by HOTAIR regulates the progression of gastrointestinal stromal tumors
por: Lee, Na Keum, et al.
Publicado: (2016) -
Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer
por: Lin, Ying-Li, et al.
Publicado: (2014) -
PCDH18 is frequently inactivated by promoter methylation in colorectal cancer
por: Zhou, Dan, et al.
Publicado: (2017) -
The role of Pcdh10 in neurological disease and cancer
por: Zhen, Yilan, et al.
Publicado: (2023)